Author:
Shin Sang-Chul,Choi Jun-Shik
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference36 articles.
1. Use of tamoxifen for breast cancer: twenty-eight years later;Jaiyesimi;J Clin Oncol,1995
2. Tamoxifen: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use;Buckley;Clin Pharmacokin,1989
3. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen, I. Cytochrome P450-catalysed N-demethylation and 4-hydroxylation;Mani;Drug Metab Dispos,1993
4. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes;Crewe;Biochem Pharmacol,1997
5. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues;Borgna;J Biol Chem,1981
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献